ホーム > サポート > 参考文献

参考文献

Receptor-Interacting Protein 3/Calmodulin-Dependent Kinase II/Proline-Rich Tyrosine Kinase 2 Pathway is Involved in Programmed Cell Death in a Mouse Model of Brain Ischaemic Stroke

Wang B, Ma L, Liu L, et al. Receptor-Interacting Protein 3/Calmodulin-Dependent Kinase II/Proline-Rich Tyrosine Kinase 2 Pathway is Involved in Programmed Cell Death in a Mouse Model of Brain Ischaemic Stroke. Neuroscience. 2022;506:14-28. doi:10.1016/j.neuroscience.2022.09.009

製品推奨: GAPDH 購入元: abinScience 2022-12-01
Design and Structural Optimization of Orally Bioavailable SOS1 Inhibitors for the Treatment of KRAS-Driven Carcinoma

He, H., Zhang, Y., Xu, J., Liu, Y., Wang, Z., Li, Y.,... & Zhang, S. (2022). Design and Structural Optimization of Orally Bioavailable SOS1 Inhibitors for the Treatment of KRAS-Driven Carcinoma. Journal of Medicinal Chemistry, 65(23), 16001-16016.

製品推奨: Recombinant Human KRAS/K-Ras 2 (G12C) Protein 購入元: abinScience 2022-11-17
Design and Structural Optimization of Orally Bioavailable SOS1 Inhibitors for the Treatment of KRAS-Driven Carcinoma

He, H., Zhang, Y., Xu, J., Liu, Y., Wang, Z., Li, Y.,... & Zhang, S. (2022). Design and Structural Optimization of Orally Bioavailable SOS1 Inhibitors for the Treatment of KRAS-Driven Carcinoma. Journal of Medicinal Chemistry, 65(23), 16001-16016.

製品推奨: Recombinant Human KRAS/K-Ras 2 (G12C) Protein 購入元: abinScience 2022-11-17
Molecular mimicry of the receptor-binding domain of the SARS-CoV-2 spike protein: from the interaction of spike-specific antibodies with transferrin and lactoferrin to the antiviral effects of human recombinant lactoferrin

Sokolov, A. V., Isakova‑Sivak, I. N., Mezhenskaya, D. A., Kostevich, V. A., Gorbunov, N. P., Elizarova, A. Yu., Matyushenko, V. A., Berson, Yu. M., Grudinina, N. A., Kolmakov, N. N., Zabrodskaya, Y. A., Komlev, A. S., Semak, I. V., Budevich, A. I., Rudenko, L. G., Vasilyev, V. B. (2022). Molecular mimicry of the receptor-binding domain of the SARS‑CoV‑2 spike protein: from the interaction of spike‑specific antibodies with transferrin and lactoferrin to the antiviral effects of human recombinant lactoferrin. Biometals, 36(3), 437–462.

製品推奨: Recombinant SARS-CoV-2 S - Trimer 購入元: abinScience 2022-11-05
Molecular mimicry of the receptor-binding domain of the SARS-CoV-2 spike protein: from the interaction of spike-specific antibodies with transferrin and lactoferrin to the antiviral effects of human recombinant lactoferrin

Sokolov, A. V., Isakova‑Sivak, I. N., Mezhenskaya, D. A., Kostevich, V. A., Gorbunov, N. P., Elizarova, A. Yu., Matyushenko, V. A., Berson, Yu. M., Grudinina, N. A., Kolmakov, N. N., Zabrodskaya, Y. A., Komlev, A. S., Semak, I. V., Budevich, A. I., Rudenko, L. G., Vasilyev, V. B. (2022). Molecular mimicry of the receptor-binding domain of the SARS‑CoV‑2 spike protein: from the interaction of spike‑specific antibodies with transferrin and lactoferrin to the antiviral effects of human recombinant lactoferrin. Biometals, 36(3), 437–462.

製品推奨: Recombinant SARS-CoV-2 S - Trimer 購入元: abinScience 2022-11-05
SARS-CoV-2 evolves to reduce but not abolish neutralizing action

Zhang Y, Ndzouboukou JB, Lin X, et al. SARS-CoV-2 evolves to reduce but not abolish neutralizing action. J Med Virol. 2023;95(1):e28207. doi:10.1002/jmv.28207

製品推奨: Research Grade Bamlanivimab Research Grade Casirivimab Research Grade lmdevimab Research Grade Etesevimab 購入元: abinScience 2022-10-19
SARS-CoV-2 evolves to reduce but not abolish neutralizing action

Zhang Y, Ndzouboukou JB, Lin X, et al. SARS-CoV-2 evolves to reduce but not abolish neutralizing action. J Med Virol. 2023;95(1):e28207. doi:10.1002/jmv.28207

製品推奨: Research Grade Bamlanivimab Research Grade Casirivimab Research Grade lmdevimab Research Grade Etesevimab 購入元: abinScience 2022-10-19
Discovery of Orally Bioavailable SOS1 Inhibitors for Suppressing KRAS-Driven Carcinoma

He, H., Zhang, Y., Xu, J., Li, Y., Fang, H., Liu, Y., Zhang, S., … (2022). Discovery of orally bioavailable SOS1 inhibitors for suppressing KRAS‑driven carcinoma. Journal of Medicinal Chemistry, 65(19), 13158–13171.

製品推奨: Recombinant Human KRAS/K-Ras 2 (G12C) Protein N-GST 購入元: abinScience 2022-09-29
Discovery of Orally Bioavailable SOS1 Inhibitors for Suppressing KRAS-Driven Carcinoma

He, H., Zhang, Y., Xu, J., Li, Y., Fang, H., Liu, Y., Zhang, S., … (2022). Discovery of orally bioavailable SOS1 inhibitors for suppressing KRAS‑driven carcinoma. Journal of Medicinal Chemistry, 65(19), 13158–13171.

製品推奨: Recombinant Human KRAS/K-Ras 2 (G12C) Protein N-GST 購入元: abinScience 2022-09-29
M6 A Modifier-Mediated Methylation Characterized by Diverse Prognosis, Tumor Microenvironment, and Immunother

Liu, F., et al. (2022). M6A modifier‑mediated methylation characterized by diverse prognosis, tumor microenvironment, and immunotherapy response in hepatocellular carcinoma. [Journal unspecified].

製品推奨: GAPDH 購入元: abinScience 2022-08-16

無料クォート取得